8-K: Quantum-Si Appoints PricewaterhouseCoopers as New Independent Auditor, Replacing Deloitte
Auditor Change Announcement
Quantum-Si Incorporated has appointed PricewaterhouseCoopers as its new independent auditor, replacing Deloitte & Touche, effective for the fiscal year ending December 31, 2024.
Summary
- Quantum-Si Incorporated has changed its independent registered public accounting firm from Deloitte & Touche LLP to PricewaterhouseCoopers LLP, effective June 4, 2024.
- The change was approved by the Audit Committee of the Board of Directors.
- Deloitte's audit reports for the fiscal years ending December 31, 2023 and 2022 did not contain any adverse opinions, disclaimers, or qualifications.
- There were no disagreements with Deloitte on accounting principles, financial statement disclosure, or auditing scope during the fiscal years 2023 and 2022 and the subsequent interim period through June 4, 2024.
- Material weaknesses in internal control over financial reporting were disclosed in 2022 filings related to the accounting of warrants and the lack of an internal finance function.
- Deloitte has authorized PwC to inquire about these reportable events.
- PwC was not consulted on accounting principles or audit opinions prior to their appointment.
Sentiment
Score: 6
Explanation: The document is neutral overall. While there are no major red flags, the previously disclosed material weaknesses in internal control are a concern. The change of auditors is not unexpected and the appointment of PwC is generally seen as positive.
Positives
- The transition to a new auditor appears to be orderly, with no reported disagreements with the previous auditor, Deloitte.
- Deloitte's audit reports for the past two years were clean, indicating no major issues with the company's financial statements.
- PwC's appointment suggests a fresh perspective on the company's financial reporting.
Negatives
- Material weaknesses in internal control over financial reporting were identified in 2022, specifically related to warrant accounting and the lack of an internal finance function.
- The company previously outsourced its accounting and financial reporting, which led to some of the identified weaknesses.
Risks
- The material weaknesses in internal control over financial reporting, although previously disclosed, could pose ongoing risks if not fully remediated.
- The transition to a new auditor could introduce some short-term uncertainty in the financial reporting process.
- The company's past reliance on outsourced accounting services may have contributed to the identified weaknesses.
Future Outlook
The company will be working with PwC for the fiscal year ending December 31, 2024.
Management Comments
- The Audit Committee of the Board of Directors appointed PwC as the company's independent registered public accounting firm.
- The Audit Committee also dismissed Deloitte as the company's independent registered public accounting firm.
Industry Context
Changes in auditors are not uncommon, but it is important to note that the company has had material weaknesses in internal controls in the past. This change may be part of an effort to improve financial reporting and internal controls.
Comparison to Industry Standards
- The change of auditors is a common practice in the industry, and the appointment of a Big Four firm like PwC is generally seen as a positive step.
- The disclosure of material weaknesses in internal control is not uncommon, but it is important for the company to demonstrate that these issues are being addressed.
- Companies in the biotech and life sciences sector often face challenges in establishing robust internal controls, especially during early stages of growth.
Stakeholder Impact
- Shareholders may view the change of auditors as a positive step towards improving financial reporting.
- Employees in the finance and accounting department will need to work with the new auditor.
- Creditors and suppliers may be reassured by the appointment of a reputable auditor like PwC.
Next Steps
- PwC will conduct the audit for the fiscal year ending December 31, 2024.
- The company will need to address the previously identified material weaknesses in internal control.
Key Dates
| Date | Description |
|---|---|
| 2022-12-31 | End of fiscal year for which Deloitte issued an audit report. |
| 2023-12-31 | End of fiscal year for which Deloitte issued an audit report. |
| 2024-06-04 | Date of appointment of PwC and dismissal of Deloitte as independent auditor. |
| 2024-06-07 | Date of Deloitte's letter to the SEC regarding the auditor change. |
Keywords
auditor, PricewaterhouseCoopers, Deloitte, accounting, financial reporting, internal control, warrants, audit committee
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.